Sickle cell anemia and COVID-19: Use of voxelotor to avoid transfusion

Transfusion. 2020 Dec;60(12):3066-3067. doi: 10.1111/trf.16068. Epub 2020 Sep 24.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Anemia, Sickle Cell / blood
  • Anemia, Sickle Cell / complications*
  • Anemia, Sickle Cell / drug therapy
  • Anemia, Sickle Cell / therapy
  • Benzaldehydes / therapeutic use*
  • COVID-19 / complications*
  • COVID-19 / diagnosis
  • COVID-19 Nucleic Acid Testing
  • Combined Modality Therapy
  • Erythrocyte Transfusion
  • Female
  • Hematologic Agents / therapeutic use*
  • Hemoglobins / analysis
  • Humans
  • Hypoxia / etiology
  • Pyrazines / therapeutic use*
  • Pyrazoles / therapeutic use*

Substances

  • Benzaldehydes
  • Hematologic Agents
  • Hemoglobins
  • Pyrazines
  • Pyrazoles
  • voxelotor